ATEM Capital

ATEM Capital invests in innovations across the Life Sciences industry with the promise to cure once-incurable diseases that help people live longer. Our target technologies are breakthroughs with unmet clinical need, strong IP protection, and the appeal to become a must-have for strategic players. We completed many successful transactions with a superior return on invested capital in partnerships with the leading US and EU venture groups. ATEM acts in strategic partnerships with the world’s leading venture firms and possesses critical mass, top-notch expertise, industrial quality diligence, and professional board-level control to identify superior technologies with healthy returns to investors.